Geneva, March 20 -- International Clinical Trials Registry received information related to the study (RPCEC00000471) titled 'Evaluation of the effect of the SymBiElle for vaginal health' on Feb. 26.
Study Type: Interventional
Study Design:
Allocation: Randomized controlled trial. Masking: Double Blind. Control group: Placebo. Assignment: Parallel. Purpose: Treatment
Primary Sponsor: Hermanos Ameijeiras Surgical Clinical Hospital
Condition:
Recurrent vulvovaginal candidiases
Intervention:
Group I - SymBiElle (Experimental): Participants will receive 1 capsule of SymBiElle by oral route, every 12 hours with meals (2 capsules per day in total) for 90 days. The capsule is a cooperative microbial consortium, formulated based on ecologi...